Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

The stock's fall snapped a four-day winning streak.

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Morgan Stanley. Looking at options history for Morgan Stanley MS we detected 18 trades. If we consider the specifics of ...

Nvidia’s (NASDAQ:NVDA) seemingly never-ending surge has been more muted in recent times. While sentiment has far from soured ...

A portfolio of Brightview Senior Living communities spanning four markets, including Philadelphia, has sold to one of America ...